Project
avrg: GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for HOXB2_UNCX_HOXD3
Z-value: 3.15
Motif logo
Transcription factors associated with HOXB2_UNCX_HOXD3
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
HOXB2
|
ENSG00000173917.11 | HOXB2 |
|
UNCX
|
ENSG00000164853.9 | UNCX |
|
HOXD3
|
ENSG00000128652.12 | HOXD3 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| HOXD3 | hg38_v1_chr2_+_176157293_176157332 | -0.37 | 2.5e-08 | Click! |
| HOXB2 | hg38_v1_chr17_-_48545077_48545117 | 0.04 | 5.2e-01 | Click! |
Activity profile of HOXB2_UNCX_HOXD3 motif
Sorted Z-values of HOXB2_UNCX_HOXD3 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of HOXB2_UNCX_HOXD3
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 7.1 | 42.8 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
| 5.5 | 16.5 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 4.7 | 18.6 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
| 4.6 | 13.9 | GO:1902594 | viral penetration into host nucleus(GO:0075732) multi-organism nuclear import(GO:1902594) |
| 4.2 | 12.7 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 3.8 | 11.4 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
| 3.1 | 15.6 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 3.1 | 12.3 | GO:0051311 | meiotic metaphase I plate congression(GO:0043060) meiotic spindle midzone assembly(GO:0051257) meiotic metaphase plate congression(GO:0051311) |
| 3.1 | 9.2 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
| 3.0 | 18.0 | GO:0070101 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) positive regulation of chemokine-mediated signaling pathway(GO:0070101) |
| 2.8 | 11.3 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
| 2.8 | 2.8 | GO:0002501 | peptide antigen assembly with MHC protein complex(GO:0002501) |
| 2.8 | 8.3 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 2.2 | 6.7 | GO:0061011 | hepatic duct development(GO:0061011) |
| 2.1 | 6.4 | GO:0099404 | negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
| 2.0 | 6.1 | GO:0034769 | basement membrane disassembly(GO:0034769) |
| 1.7 | 7.0 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) retrograde trans-synaptic signaling by soluble gas(GO:0098923) trans-synaptic signaling by soluble gas(GO:0099543) |
| 1.7 | 8.4 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
| 1.6 | 14.6 | GO:2000334 | response to linoleic acid(GO:0070543) blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
| 1.6 | 6.4 | GO:0051697 | protein delipidation(GO:0051697) |
| 1.5 | 13.9 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 1.5 | 6.2 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 1.5 | 8.8 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
| 1.4 | 9.9 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 1.4 | 18.3 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 1.4 | 4.2 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 1.4 | 4.1 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
| 1.3 | 11.9 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
| 1.3 | 3.9 | GO:1903926 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 1.3 | 15.4 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
| 1.3 | 11.4 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
| 1.3 | 5.0 | GO:0015855 | canalicular bile acid transport(GO:0015722) pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 1.2 | 4.9 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
| 1.2 | 7.3 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
| 1.1 | 6.8 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 1.1 | 6.8 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 1.1 | 6.6 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 1.1 | 1.1 | GO:1902227 | negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) |
| 1.1 | 1.1 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 1.1 | 5.4 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 1.1 | 5.3 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
| 1.0 | 3.0 | GO:2001166 | histone H3-K79 methylation(GO:0034729) regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 1.0 | 4.0 | GO:0006272 | leading strand elongation(GO:0006272) |
| 1.0 | 2.9 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
| 1.0 | 3.8 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.9 | 26.4 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
| 0.9 | 23.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.9 | 12.6 | GO:0070986 | left/right axis specification(GO:0070986) |
| 0.9 | 2.7 | GO:0060739 | mesenchymal-epithelial cell signaling involved in prostate gland development(GO:0060739) |
| 0.9 | 5.4 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.9 | 2.6 | GO:1903774 | mitotic cytokinesis checkpoint(GO:0044878) ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.9 | 3.5 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 0.9 | 5.2 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.8 | 4.2 | GO:1903904 | negative regulation of establishment of T cell polarity(GO:1903904) negative regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001107) |
| 0.8 | 4.2 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 0.8 | 8.5 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
| 0.8 | 2.5 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.8 | 3.3 | GO:0002188 | translation reinitiation(GO:0002188) |
| 0.8 | 2.4 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.8 | 2.4 | GO:0060382 | regulation of DNA strand elongation(GO:0060382) |
| 0.8 | 3.1 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 0.8 | 36.2 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.8 | 2.3 | GO:0060003 | copper ion export(GO:0060003) |
| 0.7 | 2.2 | GO:1901253 | negative regulation of intracellular transport of viral material(GO:1901253) |
| 0.7 | 9.6 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
| 0.7 | 5.2 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) negative regulation of DNA damage checkpoint(GO:2000002) |
| 0.7 | 2.9 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.7 | 3.6 | GO:0070433 | negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
| 0.7 | 17.4 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.7 | 4.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 0.7 | 3.4 | GO:1902969 | mitotic DNA replication(GO:1902969) |
| 0.7 | 4.8 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
| 0.7 | 6.8 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.7 | 4.1 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
| 0.7 | 2.0 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.7 | 8.1 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
| 0.7 | 2.7 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.7 | 2.0 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.7 | 2.0 | GO:0007518 | myoblast fate determination(GO:0007518) |
| 0.6 | 9.0 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
| 0.6 | 0.6 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.6 | 5.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.6 | 1.9 | GO:1990519 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 0.6 | 6.2 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
| 0.6 | 3.0 | GO:1903936 | cellular response to sodium arsenite(GO:1903936) |
| 0.6 | 1.8 | GO:1903542 | epidermal growth factor catabolic process(GO:0007174) negative regulation of exosomal secretion(GO:1903542) |
| 0.6 | 2.4 | GO:0009224 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.6 | 5.3 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
| 0.6 | 5.2 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.6 | 7.5 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.6 | 2.9 | GO:0061743 | motor learning(GO:0061743) |
| 0.6 | 3.4 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
| 0.6 | 2.8 | GO:1900133 | regulation of renin secretion into blood stream(GO:1900133) |
| 0.6 | 2.2 | GO:0090270 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
| 0.6 | 3.3 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
| 0.6 | 2.8 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.5 | 1.6 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.5 | 1.1 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.5 | 4.7 | GO:0009249 | protein lipoylation(GO:0009249) |
| 0.5 | 0.5 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
| 0.5 | 2.6 | GO:0009082 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.5 | 14.1 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
| 0.5 | 1.6 | GO:0002305 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
| 0.5 | 9.7 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.5 | 2.0 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
| 0.5 | 2.5 | GO:1900369 | regulation of RNA interference(GO:1900368) negative regulation of RNA interference(GO:1900369) |
| 0.5 | 3.0 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
| 0.5 | 1.5 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 0.5 | 1.5 | GO:0071283 | cellular response to iron(III) ion(GO:0071283) |
| 0.5 | 10.1 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.5 | 2.0 | GO:0035989 | tendon development(GO:0035989) |
| 0.5 | 4.5 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.5 | 2.0 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.5 | 4.4 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.5 | 1.4 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
| 0.5 | 1.9 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 0.5 | 2.8 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.5 | 1.4 | GO:0002668 | negative regulation of T cell tolerance induction(GO:0002665) negative regulation of T cell anergy(GO:0002668) negative regulation of lymphocyte anergy(GO:0002912) regulation of lymphotoxin A production(GO:0032681) positive regulation of lymphotoxin A production(GO:0032761) regulation of lymphotoxin A biosynthetic process(GO:0043016) positive regulation of lymphotoxin A biosynthetic process(GO:0043017) |
| 0.5 | 2.3 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
| 0.5 | 4.1 | GO:1904867 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
| 0.4 | 4.5 | GO:1990403 | embryonic brain development(GO:1990403) |
| 0.4 | 2.7 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.4 | 3.5 | GO:0051026 | chiasma assembly(GO:0051026) |
| 0.4 | 1.3 | GO:1904387 | response to human chorionic gonadotropin(GO:0044752) cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
| 0.4 | 5.1 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.4 | 3.9 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.4 | 2.5 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.4 | 0.8 | GO:2001202 | regulation of transforming growth factor-beta secretion(GO:2001201) negative regulation of transforming growth factor-beta secretion(GO:2001202) |
| 0.4 | 1.3 | GO:0036245 | cellular response to menadione(GO:0036245) |
| 0.4 | 2.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.4 | 1.2 | GO:0097086 | amniotic stem cell differentiation(GO:0097086) negative regulation of dense core granule biogenesis(GO:2000706) negative regulation of mesenchymal stem cell differentiation(GO:2000740) regulation of amniotic stem cell differentiation(GO:2000797) negative regulation of amniotic stem cell differentiation(GO:2000798) |
| 0.4 | 1.6 | GO:1904020 | negative regulation of clathrin-mediated endocytosis(GO:1900186) regulation of G-protein coupled receptor internalization(GO:1904020) negative regulation of G-protein coupled receptor internalization(GO:1904021) |
| 0.4 | 2.5 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.4 | 4.8 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 0.4 | 17.2 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.4 | 1.6 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
| 0.4 | 1.2 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.4 | 1.6 | GO:0015670 | carbon dioxide transport(GO:0015670) |
| 0.4 | 1.2 | GO:0034552 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.4 | 1.5 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 0.4 | 3.4 | GO:0060449 | lateral mesoderm development(GO:0048368) bud elongation involved in lung branching(GO:0060449) |
| 0.4 | 2.2 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.4 | 1.4 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.4 | 8.2 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.4 | 2.8 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
| 0.4 | 0.7 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
| 0.4 | 1.4 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) |
| 0.4 | 7.0 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.3 | 1.0 | GO:0044771 | meiotic cell cycle phase transition(GO:0044771) establishment of meiotic spindle localization(GO:0051295) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.3 | 2.4 | GO:0046449 | creatinine metabolic process(GO:0046449) |
| 0.3 | 2.4 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 0.3 | 6.1 | GO:0006105 | succinate metabolic process(GO:0006105) |
| 0.3 | 1.0 | GO:0036233 | glycine import(GO:0036233) |
| 0.3 | 1.0 | GO:0052564 | response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
| 0.3 | 0.7 | GO:0003162 | atrioventricular node development(GO:0003162) |
| 0.3 | 7.6 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
| 0.3 | 13.5 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.3 | 5.6 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.3 | 7.5 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.3 | 1.6 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.3 | 2.8 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.3 | 2.5 | GO:0030091 | protein repair(GO:0030091) |
| 0.3 | 2.2 | GO:2000489 | hepatic stellate cell activation(GO:0035733) regulation of hepatic stellate cell activation(GO:2000489) positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.3 | 1.5 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
| 0.3 | 0.9 | GO:1901874 | negative regulation of post-translational protein modification(GO:1901874) |
| 0.3 | 2.4 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.3 | 5.1 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.3 | 1.2 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 0.3 | 15.0 | GO:0048255 | mRNA stabilization(GO:0048255) |
| 0.3 | 0.9 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
| 0.3 | 3.3 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
| 0.3 | 7.1 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.3 | 2.1 | GO:1904424 | regulation of GTP binding(GO:1904424) |
| 0.3 | 13.8 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
| 0.3 | 3.8 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
| 0.3 | 1.4 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
| 0.3 | 1.4 | GO:0015692 | cadmium ion transport(GO:0015691) lead ion transport(GO:0015692) cadmium ion transmembrane transport(GO:0070574) |
| 0.3 | 3.7 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
| 0.3 | 4.5 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.3 | 3.1 | GO:0034465 | response to carbon monoxide(GO:0034465) |
| 0.3 | 3.3 | GO:0051382 | kinetochore assembly(GO:0051382) |
| 0.3 | 7.4 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
| 0.3 | 26.1 | GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) |
| 0.3 | 3.8 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.3 | 0.8 | GO:0071400 | carbamoyl phosphate metabolic process(GO:0070408) carbamoyl phosphate biosynthetic process(GO:0070409) cellular response to oleic acid(GO:0071400) response to ammonia(GO:1903717) cellular response to ammonia(GO:1903718) |
| 0.3 | 2.2 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 0.3 | 0.8 | GO:1990637 | response to prolactin(GO:1990637) |
| 0.3 | 1.3 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) midbrain morphogenesis(GO:1904693) |
| 0.3 | 1.8 | GO:0044245 | polysaccharide digestion(GO:0044245) |
| 0.3 | 1.8 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.3 | 4.7 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.3 | 2.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.3 | 1.0 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
| 0.3 | 1.5 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
| 0.2 | 0.7 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.2 | 3.4 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.2 | 0.5 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.2 | 1.2 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.2 | 3.4 | GO:0051661 | maintenance of centrosome location(GO:0051661) regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
| 0.2 | 1.2 | GO:0010286 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.2 | 1.4 | GO:0006547 | histamine metabolic process(GO:0001692) histidine metabolic process(GO:0006547) histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
| 0.2 | 28.1 | GO:0006414 | translational elongation(GO:0006414) |
| 0.2 | 0.9 | GO:1903803 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.2 | 0.2 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
| 0.2 | 12.2 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.2 | 1.6 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
| 0.2 | 3.0 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 0.2 | 0.9 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.2 | 2.3 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.2 | 3.4 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.2 | 0.7 | GO:0042495 | detection of bacterial lipoprotein(GO:0042494) detection of triacyl bacterial lipopeptide(GO:0042495) detection of bacterial lipopeptide(GO:0070340) |
| 0.2 | 13.6 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.2 | 2.0 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.2 | 1.1 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
| 0.2 | 1.8 | GO:0001302 | replicative cell aging(GO:0001302) |
| 0.2 | 1.1 | GO:0035926 | response to vitamin K(GO:0032571) chemokine (C-C motif) ligand 2 secretion(GO:0035926) regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
| 0.2 | 1.9 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
| 0.2 | 1.5 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.2 | 3.4 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
| 0.2 | 3.5 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.2 | 1.7 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.2 | 0.8 | GO:0070166 | enamel mineralization(GO:0070166) |
| 0.2 | 0.6 | GO:0032304 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) negative regulation of icosanoid secretion(GO:0032304) negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 0.2 | 1.0 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.2 | 5.1 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.2 | 1.2 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.2 | 2.6 | GO:0023058 | adaptation of signaling pathway(GO:0023058) |
| 0.2 | 7.6 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
| 0.2 | 0.8 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 0.2 | 3.0 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.2 | 1.6 | GO:0001675 | acrosome assembly(GO:0001675) |
| 0.2 | 4.9 | GO:0019054 | modulation by virus of host process(GO:0019054) |
| 0.2 | 2.5 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
| 0.2 | 2.5 | GO:0010510 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.2 | 1.9 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.2 | 27.8 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.2 | 1.5 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 0.2 | 2.6 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.2 | 4.3 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) |
| 0.2 | 0.7 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.2 | 2.4 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.2 | 2.5 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
| 0.2 | 5.4 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
| 0.2 | 11.3 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 0.2 | 9.5 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
| 0.2 | 17.4 | GO:0051225 | spindle assembly(GO:0051225) |
| 0.2 | 3.5 | GO:0008228 | opsonization(GO:0008228) |
| 0.2 | 1.2 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
| 0.2 | 10.1 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.2 | 2.6 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.2 | 22.6 | GO:0045047 | protein targeting to ER(GO:0045047) |
| 0.2 | 3.9 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.2 | 0.7 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
| 0.2 | 8.8 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.2 | 0.7 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.2 | 2.6 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.2 | 1.5 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.2 | 2.1 | GO:0046548 | retinal rod cell development(GO:0046548) |
| 0.2 | 3.4 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
| 0.2 | 0.6 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.2 | 1.1 | GO:0000012 | single strand break repair(GO:0000012) |
| 0.2 | 0.8 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.2 | 1.7 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.2 | 2.6 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.2 | 0.6 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
| 0.2 | 0.8 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
| 0.2 | 3.5 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.1 | 6.2 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.1 | 1.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.1 | 5.6 | GO:0019731 | antibacterial humoral response(GO:0019731) |
| 0.1 | 2.8 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
| 0.1 | 2.8 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.1 | 0.3 | GO:0048769 | sarcomerogenesis(GO:0048769) |
| 0.1 | 0.9 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
| 0.1 | 0.6 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 | 1.3 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.1 | 2.2 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.1 | 0.4 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
| 0.1 | 1.4 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.1 | 3.8 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
| 0.1 | 7.9 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.1 | 3.6 | GO:0002223 | stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
| 0.1 | 1.8 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
| 0.1 | 6.4 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
| 0.1 | 1.7 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 | 1.7 | GO:0046885 | regulation of hormone biosynthetic process(GO:0046885) |
| 0.1 | 1.7 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
| 0.1 | 0.8 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
| 0.1 | 4.8 | GO:0033198 | response to ATP(GO:0033198) |
| 0.1 | 0.8 | GO:0042407 | inner mitochondrial membrane organization(GO:0007007) cristae formation(GO:0042407) |
| 0.1 | 0.9 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.1 | 0.6 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.1 | 2.0 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
| 0.1 | 2.4 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.1 | 2.5 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 0.1 | 0.9 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.1 | 0.6 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 0.1 | 0.5 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.1 | 3.5 | GO:0006298 | mismatch repair(GO:0006298) |
| 0.1 | 0.6 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.1 | 2.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.1 | 2.5 | GO:0006825 | copper ion transport(GO:0006825) |
| 0.1 | 0.2 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.1 | 1.3 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.1 | 5.5 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
| 0.1 | 0.7 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.1 | 1.5 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.1 | 5.6 | GO:0006446 | regulation of translational initiation(GO:0006446) |
| 0.1 | 1.1 | GO:0015846 | polyamine transport(GO:0015846) |
| 0.1 | 0.2 | GO:0048840 | otolith development(GO:0048840) |
| 0.1 | 5.7 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
| 0.1 | 0.9 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.1 | 2.4 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
| 0.1 | 1.4 | GO:0030953 | astral microtubule organization(GO:0030953) |
| 0.1 | 2.6 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
| 0.1 | 6.3 | GO:0002062 | chondrocyte differentiation(GO:0002062) |
| 0.1 | 3.3 | GO:0000154 | rRNA modification(GO:0000154) |
| 0.1 | 8.6 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
| 0.1 | 1.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.1 | 0.2 | GO:0016068 | regulation of type I hypersensitivity(GO:0001810) positive regulation of type I hypersensitivity(GO:0001812) type I hypersensitivity(GO:0016068) |
| 0.1 | 0.2 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
| 0.1 | 0.5 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
| 0.1 | 2.2 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
| 0.1 | 0.4 | GO:0035627 | ceramide transport(GO:0035627) |
| 0.1 | 0.3 | GO:0001188 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.1 | 0.4 | GO:0061358 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) negative regulation of Wnt protein secretion(GO:0061358) |
| 0.1 | 0.6 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
| 0.1 | 0.4 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
| 0.1 | 2.3 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.1 | 6.6 | GO:2000177 | regulation of neural precursor cell proliferation(GO:2000177) |
| 0.1 | 0.4 | GO:0033306 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
| 0.1 | 0.2 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) endocardial cushion to mesenchymal transition(GO:0090500) |
| 0.1 | 2.8 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.1 | 0.3 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.1 | 0.4 | GO:0034445 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 0.1 | 0.4 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.1 | 1.5 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
| 0.1 | 10.8 | GO:0031424 | keratinization(GO:0031424) |
| 0.1 | 0.4 | GO:0019048 | modulation by virus of host morphology or physiology(GO:0019048) |
| 0.1 | 0.6 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
| 0.1 | 0.3 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) |
| 0.1 | 0.8 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
| 0.1 | 0.3 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
| 0.1 | 0.9 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.1 | 4.9 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
| 0.1 | 1.5 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.1 | 1.1 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
| 0.1 | 1.8 | GO:0045056 | transcytosis(GO:0045056) |
| 0.1 | 1.2 | GO:0046085 | adenosine metabolic process(GO:0046085) |
| 0.1 | 1.3 | GO:0031935 | regulation of chromatin silencing(GO:0031935) |
| 0.1 | 2.2 | GO:0002076 | osteoblast development(GO:0002076) |
| 0.1 | 1.6 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
| 0.1 | 1.0 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.1 | 1.1 | GO:0000717 | nucleotide-excision repair, DNA duplex unwinding(GO:0000717) nucleotide-excision repair, preincision complex stabilization(GO:0006293) |
| 0.1 | 1.3 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.1 | 2.3 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
| 0.1 | 0.8 | GO:0008343 | adult feeding behavior(GO:0008343) |
| 0.1 | 23.8 | GO:0000398 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
| 0.1 | 1.8 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.1 | 0.5 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.1 | 0.2 | GO:1903939 | regulation of TORC2 signaling(GO:1903939) |
| 0.1 | 1.5 | GO:0010659 | cardiac muscle cell apoptotic process(GO:0010659) |
| 0.1 | 1.6 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
| 0.1 | 3.6 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.1 | 0.4 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.1 | 0.7 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.1 | 0.7 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
| 0.1 | 0.8 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
| 0.1 | 3.4 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
| 0.1 | 1.8 | GO:0032873 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
| 0.1 | 2.5 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.1 | 0.9 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
| 0.1 | 0.3 | GO:0014877 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.1 | 0.3 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 0.1 | 1.8 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.1 | 0.5 | GO:0001865 | NK T cell differentiation(GO:0001865) |
| 0.1 | 3.5 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
| 0.1 | 0.3 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.1 | 4.4 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.1 | 1.4 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.1 | 0.8 | GO:0060117 | auditory receptor cell development(GO:0060117) |
| 0.1 | 0.2 | GO:1901838 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.1 | 0.3 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
| 0.1 | 1.2 | GO:0042255 | ribosome assembly(GO:0042255) |
| 0.1 | 0.6 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.1 | 0.8 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.1 | 1.0 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.1 | 3.8 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
| 0.1 | 0.2 | GO:0031455 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.1 | 0.5 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.1 | 0.2 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
| 0.1 | 0.4 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 0.1 | 1.1 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
| 0.1 | 0.3 | GO:0009441 | glycolate metabolic process(GO:0009441) |
| 0.1 | 1.0 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.1 | 0.4 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
| 0.1 | 0.2 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.1 | 0.4 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
| 0.1 | 0.8 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
| 0.1 | 1.8 | GO:0030032 | lamellipodium assembly(GO:0030032) |
| 0.1 | 1.6 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.1 | 0.8 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.1 | 2.2 | GO:0010107 | potassium ion import(GO:0010107) |
| 0.0 | 1.0 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.0 | 4.5 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.0 | 2.1 | GO:0045638 | negative regulation of myeloid cell differentiation(GO:0045638) |
| 0.0 | 2.4 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
| 0.0 | 0.6 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.0 | 5.5 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
| 0.0 | 0.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.0 | 1.7 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
| 0.0 | 0.9 | GO:0030488 | tRNA methylation(GO:0030488) |
| 0.0 | 1.0 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
| 0.0 | 1.2 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.0 | 0.3 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
| 0.0 | 0.3 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
| 0.0 | 0.3 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
| 0.0 | 0.4 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
| 0.0 | 1.7 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
| 0.0 | 0.2 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
| 0.0 | 0.1 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.0 | 0.4 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.0 | 0.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.0 | 0.7 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.0 | 0.2 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 0.0 | 0.7 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
| 0.0 | 0.2 | GO:0036499 | PERK-mediated unfolded protein response(GO:0036499) |
| 0.0 | 0.5 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.0 | 0.3 | GO:0060009 | Sertoli cell development(GO:0060009) |
| 0.0 | 0.4 | GO:1903313 | positive regulation of mRNA metabolic process(GO:1903313) |
| 0.0 | 0.1 | GO:0019878 | lysine biosynthetic process(GO:0009085) lysine biosynthetic process via aminoadipic acid(GO:0019878) L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.0 | 1.8 | GO:0051028 | mRNA transport(GO:0051028) |
| 0.0 | 0.2 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.0 | 0.1 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.0 | 0.4 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
| 0.0 | 1.3 | GO:0048066 | developmental pigmentation(GO:0048066) |
| 0.0 | 1.6 | GO:0031295 | T cell costimulation(GO:0031295) |
| 0.0 | 0.2 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) pyrimidine ribonucleoside catabolic process(GO:0046133) |
| 0.0 | 1.4 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
| 0.0 | 0.6 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
| 0.0 | 1.9 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
| 0.0 | 0.2 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
| 0.0 | 1.0 | GO:0001843 | neural tube closure(GO:0001843) tube closure(GO:0060606) |
| 0.0 | 0.1 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 0.0 | 2.4 | GO:0051017 | actin filament bundle assembly(GO:0051017) |
| 0.0 | 1.4 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
| 0.0 | 0.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.0 | 0.7 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
| 0.0 | 1.1 | GO:0006364 | rRNA processing(GO:0006364) |
| 0.0 | 0.1 | GO:0070305 | response to cGMP(GO:0070305) |
| 0.0 | 0.0 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) axial mesoderm development(GO:0048318) |
| 0.0 | 0.9 | GO:0061351 | neural precursor cell proliferation(GO:0061351) |
| 0.0 | 2.6 | GO:0045732 | positive regulation of protein catabolic process(GO:0045732) |
| 0.0 | 0.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.0 | 0.1 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.0 | 1.0 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.0 | 0.2 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.0 | 0.4 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.0 | 0.1 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 0.0 | 0.0 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.0 | 0.4 | GO:0000272 | polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.0 | 0.2 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.0 | 0.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.0 | 0.1 | GO:0009648 | photoperiodism(GO:0009648) |
| 0.0 | 0.0 | GO:0097272 | ammonia homeostasis(GO:0097272) |
| 0.0 | 0.4 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
| 0.0 | 0.1 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
| 0.0 | 0.4 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
| 0.0 | 0.3 | GO:0048477 | oogenesis(GO:0048477) |
| 0.0 | 0.6 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.0 | 0.2 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.3 | 62.9 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 3.1 | 12.3 | GO:0005715 | late recombination nodule(GO:0005715) |
| 2.8 | 8.3 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
| 2.1 | 6.4 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
| 2.0 | 6.0 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 1.9 | 11.6 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 1.7 | 18.3 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 1.5 | 4.6 | GO:0071753 | IgM immunoglobulin complex(GO:0071753) IgM immunoglobulin complex, circulating(GO:0071754) pentameric IgM immunoglobulin complex(GO:0071756) |
| 1.5 | 16.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 1.4 | 11.4 | GO:0005827 | polar microtubule(GO:0005827) |
| 1.4 | 9.9 | GO:0044326 | dendritic spine neck(GO:0044326) |
| 1.4 | 6.8 | GO:0031523 | Myb complex(GO:0031523) |
| 1.3 | 11.3 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 1.2 | 6.2 | GO:0005726 | perichromatin fibrils(GO:0005726) |
| 1.2 | 3.6 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 1.2 | 8.4 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 1.1 | 5.7 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
| 1.1 | 3.4 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 1.1 | 11.0 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 1.1 | 4.2 | GO:0000811 | GINS complex(GO:0000811) |
| 1.0 | 4.0 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
| 1.0 | 4.9 | GO:0045257 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 1.0 | 17.6 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 1.0 | 3.8 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 0.9 | 3.6 | GO:0035841 | new growing cell tip(GO:0035841) |
| 0.9 | 6.1 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.8 | 3.4 | GO:0044307 | dendritic branch(GO:0044307) |
| 0.8 | 9.9 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.8 | 13.9 | GO:0044613 | nuclear pore central transport channel(GO:0044613) nuclear pore nuclear basket(GO:0044615) |
| 0.8 | 4.0 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.8 | 4.0 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 0.8 | 7.2 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.8 | 9.3 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.8 | 3.8 | GO:0032044 | DSIF complex(GO:0032044) |
| 0.7 | 4.3 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 0.7 | 2.8 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
| 0.7 | 2.8 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.7 | 8.9 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 0.7 | 6.7 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.7 | 2.0 | GO:0005592 | collagen type XI trimer(GO:0005592) |
| 0.7 | 2.7 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.7 | 7.9 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.6 | 4.5 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.6 | 2.5 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
| 0.6 | 1.9 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
| 0.6 | 8.0 | GO:0005688 | U6 snRNP(GO:0005688) |
| 0.6 | 14.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
| 0.6 | 7.0 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.6 | 11.8 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.5 | 2.2 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.5 | 1.1 | GO:0031261 | nuclear pre-replicative complex(GO:0005656) DNA replication preinitiation complex(GO:0031261) pre-replicative complex(GO:0036387) |
| 0.5 | 1.5 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.5 | 2.5 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.5 | 4.2 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 0.5 | 2.8 | GO:0097422 | tubular endosome(GO:0097422) |
| 0.5 | 3.3 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.5 | 1.9 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 0.5 | 5.1 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.5 | 6.4 | GO:0070938 | contractile ring(GO:0070938) |
| 0.5 | 16.7 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.5 | 9.0 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.4 | 10.9 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.4 | 1.3 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.4 | 0.9 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 0.4 | 11.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.4 | 4.2 | GO:0060171 | stereocilium membrane(GO:0060171) |
| 0.4 | 5.0 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.4 | 7.4 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
| 0.4 | 1.2 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 0.4 | 2.8 | GO:1990037 | Lewy body core(GO:1990037) |
| 0.4 | 1.6 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
| 0.4 | 8.2 | GO:0000974 | Prp19 complex(GO:0000974) |
| 0.4 | 4.6 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.4 | 2.6 | GO:0090543 | Flemming body(GO:0090543) |
| 0.4 | 4.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.4 | 13.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.3 | 3.1 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.3 | 7.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.3 | 2.0 | GO:0032389 | MutLalpha complex(GO:0032389) |
| 0.3 | 2.0 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
| 0.3 | 2.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.3 | 2.8 | GO:0032010 | phagolysosome(GO:0032010) |
| 0.3 | 9.6 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
| 0.3 | 20.7 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.3 | 3.7 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.3 | 3.9 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.3 | 1.8 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
| 0.3 | 1.5 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.3 | 1.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.3 | 1.4 | GO:0070826 | paraferritin complex(GO:0070826) |
| 0.3 | 1.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.3 | 2.0 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.3 | 2.5 | GO:0032797 | SMN complex(GO:0032797) |
| 0.3 | 16.7 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.3 | 3.0 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.3 | 7.4 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.3 | 2.9 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.3 | 3.6 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
| 0.3 | 3.3 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.2 | 1.7 | GO:0031415 | NatA complex(GO:0031415) |
| 0.2 | 1.5 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.2 | 1.9 | GO:0030478 | actin cap(GO:0030478) |
| 0.2 | 11.3 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 0.2 | 2.9 | GO:0001741 | XY body(GO:0001741) |
| 0.2 | 0.7 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
| 0.2 | 2.5 | GO:0042575 | DNA polymerase complex(GO:0042575) |
| 0.2 | 10.0 | GO:0045095 | keratin filament(GO:0045095) |
| 0.2 | 3.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.2 | 2.2 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.2 | 9.1 | GO:0002102 | podosome(GO:0002102) |
| 0.2 | 1.3 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.2 | 7.1 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.2 | 3.3 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.2 | 1.2 | GO:0070187 | telosome(GO:0070187) |
| 0.2 | 1.8 | GO:0043203 | axon hillock(GO:0043203) |
| 0.2 | 0.8 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.2 | 1.7 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.2 | 3.9 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.2 | 2.0 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.2 | 19.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.2 | 2.4 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.2 | 1.7 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.2 | 8.3 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.2 | 0.9 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
| 0.2 | 2.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.2 | 3.0 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.2 | 1.0 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.2 | 0.8 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
| 0.2 | 1.1 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
| 0.2 | 12.1 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.2 | 2.6 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.2 | 1.7 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.1 | 2.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.1 | 0.7 | GO:0070552 | BRISC complex(GO:0070552) |
| 0.1 | 1.6 | GO:0034709 | methylosome(GO:0034709) |
| 0.1 | 2.1 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.1 | 1.1 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.1 | 0.7 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.1 | 0.8 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.1 | 0.5 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
| 0.1 | 8.0 | GO:0015935 | small ribosomal subunit(GO:0015935) cytosolic small ribosomal subunit(GO:0022627) |
| 0.1 | 4.2 | GO:0000791 | euchromatin(GO:0000791) |
| 0.1 | 2.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.1 | 1.0 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) ERCC4-ERCC1 complex(GO:0070522) |
| 0.1 | 3.2 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.1 | 6.2 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
| 0.1 | 12.8 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.1 | 5.8 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.1 | 2.1 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
| 0.1 | 3.4 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.1 | 0.6 | GO:0032279 | asymmetric synapse(GO:0032279) |
| 0.1 | 4.8 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.1 | 0.5 | GO:0032585 | multivesicular body membrane(GO:0032585) |
| 0.1 | 0.8 | GO:0034464 | BBSome(GO:0034464) |
| 0.1 | 5.6 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.1 | 1.2 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.1 | 2.4 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.1 | 0.4 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
| 0.1 | 0.5 | GO:0002177 | manchette(GO:0002177) |
| 0.1 | 5.1 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
| 0.1 | 3.8 | GO:0016235 | aggresome(GO:0016235) |
| 0.1 | 0.5 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
| 0.1 | 38.6 | GO:0016607 | nuclear speck(GO:0016607) |
| 0.1 | 4.9 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.1 | 0.6 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.1 | 4.0 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
| 0.1 | 2.4 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.1 | 1.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.1 | 26.8 | GO:0098791 | Golgi subcompartment(GO:0098791) |
| 0.1 | 0.4 | GO:0032302 | MutSbeta complex(GO:0032302) |
| 0.1 | 0.4 | GO:0032437 | cuticular plate(GO:0032437) |
| 0.1 | 29.2 | GO:0030529 | intracellular ribonucleoprotein complex(GO:0030529) |
| 0.1 | 2.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.1 | 1.2 | GO:0005922 | connexon complex(GO:0005922) |
| 0.1 | 0.7 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
| 0.1 | 2.2 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.1 | 5.1 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 0.1 | 19.0 | GO:0005769 | early endosome(GO:0005769) |
| 0.1 | 2.0 | GO:0000795 | synaptonemal complex(GO:0000795) |
| 0.1 | 0.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.1 | 0.9 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.1 | 2.3 | GO:0090544 | BAF-type complex(GO:0090544) |
| 0.1 | 1.5 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.0 | 1.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.0 | 0.9 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.0 | 0.5 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.0 | 0.3 | GO:0000812 | Swr1 complex(GO:0000812) |
| 0.0 | 0.7 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
| 0.0 | 0.7 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.0 | 0.4 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.0 | 1.9 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.0 | 0.3 | GO:0030990 | intraciliary transport particle(GO:0030990) |
| 0.0 | 0.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.0 | 2.8 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
| 0.0 | 1.4 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.0 | 1.8 | GO:0005776 | autophagosome(GO:0005776) |
| 0.0 | 5.2 | GO:0000790 | nuclear chromatin(GO:0000790) |
| 0.0 | 2.0 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.0 | 12.0 | GO:0005667 | transcription factor complex(GO:0005667) |
| 0.0 | 3.2 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.0 | 0.2 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.0 | 2.4 | GO:0031970 | organelle envelope lumen(GO:0031970) |
| 0.0 | 0.3 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.0 | 0.3 | GO:0016342 | catenin complex(GO:0016342) |
| 0.0 | 2.7 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
| 0.0 | 5.1 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
| 0.0 | 3.1 | GO:0000785 | chromatin(GO:0000785) |
| 0.0 | 0.5 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
| 0.0 | 0.5 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.0 | 2.5 | GO:0034705 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
| 0.0 | 2.9 | GO:0008021 | synaptic vesicle(GO:0008021) |
| 0.0 | 0.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.0 | 0.1 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.0 | 3.2 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.0 | 0.1 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
| 0.0 | 0.7 | GO:0032993 | protein-DNA complex(GO:0032993) |
| 0.0 | 0.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.0 | 0.3 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 0.0 | 0.9 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.0 | 0.5 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.0 | 0.0 | GO:0071920 | cleavage body(GO:0071920) |
| 0.0 | 0.3 | GO:0097228 | sperm principal piece(GO:0097228) |
| 0.0 | 0.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.8 | 11.4 | GO:0031208 | POZ domain binding(GO:0031208) |
| 2.8 | 13.8 | GO:0017161 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
| 2.7 | 18.6 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 2.3 | 6.8 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 2.2 | 6.6 | GO:0070538 | oleic acid binding(GO:0070538) |
| 1.9 | 11.3 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
| 1.9 | 18.8 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 1.9 | 7.5 | GO:0004488 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
| 1.8 | 14.6 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
| 1.7 | 8.7 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 1.7 | 6.8 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
| 1.7 | 8.5 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
| 1.7 | 8.4 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 1.7 | 5.0 | GO:0015265 | urea channel activity(GO:0015265) |
| 1.6 | 9.6 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
| 1.6 | 12.7 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 1.6 | 40.8 | GO:0031489 | myosin V binding(GO:0031489) |
| 1.5 | 10.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 1.4 | 5.4 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 1.3 | 4.0 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
| 1.3 | 6.6 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 1.2 | 4.9 | GO:0051538 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 1.1 | 5.6 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
| 1.1 | 3.4 | GO:0008988 | rRNA (adenine-N6-)-methyltransferase activity(GO:0008988) |
| 1.1 | 12.7 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
| 1.0 | 7.1 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 1.0 | 11.6 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 1.0 | 6.7 | GO:0015266 | protein channel activity(GO:0015266) |
| 0.9 | 3.8 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
| 0.9 | 4.5 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
| 0.9 | 3.5 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.9 | 12.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.9 | 5.2 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.8 | 4.2 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 0.8 | 31.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.8 | 3.3 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
| 0.8 | 3.3 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
| 0.8 | 4.8 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.8 | 6.3 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.8 | 36.2 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.8 | 2.3 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.7 | 5.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.7 | 5.7 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
| 0.7 | 5.6 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 0.7 | 14.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.7 | 4.9 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.7 | 8.3 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.7 | 6.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
| 0.7 | 2.1 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
| 0.7 | 3.4 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
| 0.7 | 2.7 | GO:0050211 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) procollagen galactosyltransferase activity(GO:0050211) |
| 0.7 | 2.0 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
| 0.7 | 7.2 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
| 0.6 | 9.1 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
| 0.6 | 22.0 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.6 | 1.9 | GO:1902271 | D3 vitamins binding(GO:1902271) |
| 0.6 | 2.5 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 0.6 | 3.8 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
| 0.6 | 1.9 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
| 0.6 | 13.6 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.6 | 2.4 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.6 | 10.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.6 | 16.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.6 | 1.8 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
| 0.6 | 26.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.6 | 5.2 | GO:0030621 | U4 snRNA binding(GO:0030621) |
| 0.6 | 1.1 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 0.5 | 1.6 | GO:0098519 | polynucleotide 5'-phosphatase activity(GO:0004651) nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.5 | 13.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.5 | 6.5 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.5 | 3.3 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.5 | 6.4 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 0.5 | 2.6 | GO:0004084 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.5 | 4.1 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.5 | 2.5 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
| 0.5 | 1.5 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 0.5 | 1.0 | GO:0043682 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
| 0.5 | 13.4 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.5 | 2.4 | GO:0019862 | IgA binding(GO:0019862) |
| 0.5 | 2.8 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.5 | 2.8 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.5 | 4.6 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.5 | 5.0 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.4 | 1.7 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
| 0.4 | 1.3 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.4 | 5.1 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 0.4 | 1.3 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
| 0.4 | 7.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.4 | 1.2 | GO:0050146 | nucleoside phosphotransferase activity(GO:0050146) |
| 0.4 | 2.4 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.4 | 1.2 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
| 0.4 | 1.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 0.4 | 1.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
| 0.4 | 1.6 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
| 0.4 | 0.8 | GO:0001132 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
| 0.4 | 3.8 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.4 | 0.8 | GO:0005174 | CD40 receptor binding(GO:0005174) |
| 0.4 | 1.1 | GO:0033699 | phosphoglycolate phosphatase activity(GO:0008967) DNA 5'-adenosine monophosphate hydrolase activity(GO:0033699) |
| 0.4 | 12.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.4 | 9.8 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
| 0.4 | 2.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.4 | 2.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.3 | 1.0 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
| 0.3 | 4.1 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
| 0.3 | 2.8 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.3 | 2.4 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
| 0.3 | 4.1 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.3 | 3.1 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.3 | 1.7 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
| 0.3 | 16.2 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.3 | 2.4 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.3 | 2.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.3 | 1.0 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.3 | 1.0 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.3 | 6.3 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.3 | 1.7 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.3 | 1.0 | GO:0045550 | geranylgeranyl reductase activity(GO:0045550) |
| 0.3 | 2.5 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 0.3 | 5.0 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.3 | 0.6 | GO:1990763 | arrestin family protein binding(GO:1990763) |
| 0.3 | 7.9 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.3 | 1.5 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 0.3 | 2.7 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.3 | 3.6 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.3 | 5.0 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.3 | 9.1 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.3 | 3.5 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
| 0.3 | 1.2 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
| 0.3 | 1.4 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
| 0.3 | 1.4 | GO:0015093 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) ferrous iron transmembrane transporter activity(GO:0015093) lead ion transmembrane transporter activity(GO:0015094) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
| 0.3 | 2.9 | GO:0031013 | troponin I binding(GO:0031013) |
| 0.3 | 3.1 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.3 | 1.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.3 | 11.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.3 | 0.8 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.3 | 6.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.3 | 9.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.3 | 7.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.3 | 1.0 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
| 0.3 | 1.5 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.2 | 0.7 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.2 | 0.7 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 0.2 | 2.9 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
| 0.2 | 6.8 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.2 | 0.7 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
| 0.2 | 1.4 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.2 | 0.9 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.2 | 3.9 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.2 | 0.7 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
| 0.2 | 1.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.2 | 1.8 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
| 0.2 | 0.7 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 0.2 | 3.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.2 | 0.9 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
| 0.2 | 0.6 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
| 0.2 | 1.5 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
| 0.2 | 1.7 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.2 | 1.7 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.2 | 1.5 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.2 | 11.3 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.2 | 6.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.2 | 0.8 | GO:0004088 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
| 0.2 | 2.8 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.2 | 3.4 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 0.2 | 4.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.2 | 1.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
| 0.2 | 0.6 | GO:0004577 | N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity(GO:0004577) |
| 0.2 | 2.2 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
| 0.2 | 1.4 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
| 0.2 | 1.0 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 0.2 | 0.6 | GO:0008431 | vitamin E binding(GO:0008431) |
| 0.2 | 1.5 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
| 0.2 | 5.0 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.2 | 0.6 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 0.2 | 2.0 | GO:0030983 | mismatched DNA binding(GO:0030983) |
| 0.2 | 2.8 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.2 | 0.5 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.2 | 3.7 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.2 | 8.3 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.2 | 10.7 | GO:0005507 | copper ion binding(GO:0005507) |
| 0.2 | 1.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.2 | 0.7 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.2 | 13.6 | GO:0097110 | scaffold protein binding(GO:0097110) |
| 0.2 | 6.5 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.2 | 5.9 | GO:0043022 | ribosome binding(GO:0043022) |
| 0.2 | 2.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.2 | 6.0 | GO:0070717 | poly-purine tract binding(GO:0070717) |
| 0.2 | 1.2 | GO:0070699 | type II activin receptor binding(GO:0070699) |
| 0.2 | 1.5 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
| 0.1 | 0.6 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.1 | 2.2 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.1 | 0.4 | GO:0034061 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) DNA polymerase activity(GO:0034061) |
| 0.1 | 0.4 | GO:0030290 | sphingolipid activator protein activity(GO:0030290) beta-N-acetylgalactosaminidase activity(GO:0032428) |
| 0.1 | 1.6 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
| 0.1 | 5.6 | GO:0045182 | translation regulator activity(GO:0045182) |
| 0.1 | 0.6 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
| 0.1 | 2.8 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.1 | 3.1 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.1 | 0.6 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.1 | 0.4 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 0.1 | 1.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.1 | 1.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 0.1 | 1.0 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.1 | 7.2 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
| 0.1 | 0.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.1 | 4.0 | GO:0030515 | snoRNA binding(GO:0030515) |
| 0.1 | 25.9 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.1 | 0.7 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.1 | 4.3 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.1 | 3.3 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.1 | 0.7 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
| 0.1 | 0.4 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
| 0.1 | 2.4 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.1 | 0.5 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
| 0.1 | 4.5 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
| 0.1 | 4.7 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.1 | 0.9 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.1 | 0.4 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
| 0.1 | 18.1 | GO:0003823 | antigen binding(GO:0003823) |
| 0.1 | 0.7 | GO:0042287 | MHC protein binding(GO:0042287) |
| 0.1 | 2.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
| 0.1 | 1.0 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.1 | 0.9 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
| 0.1 | 2.7 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.1 | 3.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.1 | 3.9 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.1 | 1.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.1 | 26.8 | GO:0001047 | core promoter binding(GO:0001047) |
| 0.1 | 2.2 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.1 | 3.9 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.1 | 8.4 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.1 | 9.2 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
| 0.1 | 2.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.1 | 1.7 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.1 | 0.6 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
| 0.1 | 0.4 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
| 0.1 | 0.4 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
| 0.1 | 2.2 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.1 | 0.4 | GO:0004979 | beta-endorphin receptor activity(GO:0004979) morphine receptor activity(GO:0038047) |
| 0.1 | 5.0 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.1 | 5.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.1 | 4.6 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
| 0.1 | 1.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.1 | 0.4 | GO:0016524 | latrotoxin receptor activity(GO:0016524) |
| 0.1 | 1.7 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.1 | 0.3 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
| 0.1 | 6.6 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
| 0.1 | 0.7 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
| 0.1 | 5.8 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
| 0.1 | 1.8 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
| 0.1 | 1.5 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.1 | 0.6 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.1 | 8.3 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.1 | 2.2 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.1 | 0.5 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.1 | 0.5 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 0.1 | 0.7 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
| 0.1 | 0.2 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.1 | 0.7 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
| 0.1 | 2.8 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.1 | 1.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.1 | 1.4 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
| 0.1 | 1.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.1 | 0.7 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
| 0.1 | 1.6 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
| 0.1 | 2.2 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.1 | 3.8 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.1 | 0.4 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 0.1 | 0.7 | GO:0001851 | complement component C3b binding(GO:0001851) |
| 0.1 | 2.2 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
| 0.1 | 0.6 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
| 0.1 | 1.0 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
| 0.1 | 1.6 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.1 | 0.8 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
| 0.1 | 0.2 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.1 | 1.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.1 | 5.0 | GO:0009055 | electron carrier activity(GO:0009055) |
| 0.1 | 1.8 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.1 | 1.0 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.1 | 1.0 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.1 | 0.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.1 | 0.4 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 0.1 | 6.0 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.1 | 2.7 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.1 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.1 | 0.3 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
| 0.0 | 3.1 | GO:0019003 | GDP binding(GO:0019003) |
| 0.0 | 0.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.0 | 0.2 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
| 0.0 | 1.9 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
| 0.0 | 1.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.0 | 0.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
| 0.0 | 0.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
| 0.0 | 0.6 | GO:0051393 | alpha-actinin binding(GO:0051393) |
| 0.0 | 0.4 | GO:0008865 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.0 | 12.8 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
| 0.0 | 1.3 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
| 0.0 | 0.2 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
| 0.0 | 0.8 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
| 0.0 | 1.1 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
| 0.0 | 0.5 | GO:0032183 | SUMO binding(GO:0032183) |
| 0.0 | 1.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.0 | 1.2 | GO:0048487 | beta-tubulin binding(GO:0048487) |
| 0.0 | 0.1 | GO:0004556 | alpha-amylase activity(GO:0004556) amylase activity(GO:0016160) |
| 0.0 | 11.6 | GO:0008134 | transcription factor binding(GO:0008134) |
| 0.0 | 2.6 | GO:0008565 | protein transporter activity(GO:0008565) |
| 0.0 | 0.2 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
| 0.0 | 0.3 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
| 0.0 | 1.9 | GO:0004540 | ribonuclease activity(GO:0004540) |
| 0.0 | 0.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.0 | 7.1 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.0 | 0.4 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
| 0.0 | 0.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.0 | 0.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
| 0.0 | 0.9 | GO:0019213 | deacetylase activity(GO:0019213) |
| 0.0 | 0.4 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 0.0 | 0.3 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
| 0.0 | 0.4 | GO:0000049 | tRNA binding(GO:0000049) |
| 0.0 | 0.3 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
| 0.0 | 1.4 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
| 0.0 | 0.2 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
| 0.0 | 0.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 0.0 | 2.9 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
| 0.0 | 0.4 | GO:0004527 | exonuclease activity(GO:0004527) |
| 0.0 | 0.3 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.0 | 0.2 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
| 0.0 | 0.0 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 0.0 | 0.4 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
| 0.0 | 0.1 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.0 | 0.0 | GO:0042301 | phosphate ion binding(GO:0042301) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.8 | 43.3 | PID BARD1 PATHWAY | BARD1 signaling events |
| 0.7 | 17.6 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.7 | 18.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.6 | 30.7 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.6 | 22.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.5 | 19.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.5 | 22.7 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.4 | 19.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.3 | 34.5 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.3 | 10.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.3 | 17.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.3 | 1.5 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 0.3 | 10.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.3 | 6.5 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.3 | 2.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.3 | 15.4 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.3 | 5.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.3 | 2.2 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 0.3 | 20.2 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.3 | 0.8 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.3 | 15.3 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.2 | 7.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.2 | 12.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.2 | 14.2 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.2 | 5.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.2 | 2.6 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.2 | 8.7 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.2 | 13.2 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.2 | 3.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.2 | 13.4 | PID E2F PATHWAY | E2F transcription factor network |
| 0.2 | 0.7 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.2 | 5.1 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.2 | 8.0 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.1 | 4.8 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.1 | 2.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.1 | 0.7 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 0.1 | 3.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.1 | 7.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.1 | 5.5 | PID ATR PATHWAY | ATR signaling pathway |
| 0.1 | 5.8 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.1 | 2.8 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.1 | 0.4 | PID S1P S1P3 PATHWAY | S1P3 pathway |
| 0.1 | 0.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.1 | 3.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.1 | 4.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.1 | 1.9 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.1 | 1.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.1 | 1.0 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
| 0.1 | 2.7 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.1 | 1.6 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.1 | 3.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.1 | 3.0 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.1 | 4.6 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.1 | 1.2 | PID ATM PATHWAY | ATM pathway |
| 0.1 | 1.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.1 | 1.6 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.1 | 1.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.1 | 0.1 | ST GAQ PATHWAY | G alpha q Pathway |
| 0.1 | 1.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.1 | 0.4 | ST STAT3 PATHWAY | STAT3 Pathway |
| 0.1 | 2.0 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.1 | 1.0 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.1 | 1.8 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.1 | 2.1 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.1 | 0.6 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
| 0.1 | 3.6 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.1 | 0.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.0 | 1.2 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.0 | 3.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.0 | 1.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.0 | 1.1 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.0 | 3.1 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 0.0 | 1.6 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.0 | 0.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.0 | 0.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.0 | 0.6 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.0 | 0.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.0 | 0.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.0 | 0.2 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.6 | 38.8 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 1.5 | 54.5 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 1.1 | 10.2 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.9 | 14.7 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.9 | 17.1 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.8 | 18.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.7 | 10.4 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.7 | 16.6 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
| 0.7 | 7.6 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.6 | 1.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.6 | 16.0 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.6 | 6.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.6 | 9.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.6 | 8.4 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 0.5 | 16.7 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.5 | 47.2 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
| 0.5 | 3.9 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
| 0.5 | 3.3 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
| 0.5 | 17.3 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
| 0.5 | 2.3 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 0.5 | 13.2 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.4 | 7.0 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
| 0.4 | 2.8 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 0.4 | 6.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.4 | 12.7 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.4 | 5.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.4 | 14.0 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
| 0.4 | 7.9 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.3 | 10.5 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
| 0.3 | 5.5 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.3 | 5.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.3 | 9.0 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
| 0.3 | 3.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.3 | 3.2 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
| 0.2 | 12.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.2 | 7.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.2 | 53.1 | REACTOME TRANSLATION | Genes involved in Translation |
| 0.2 | 5.0 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.2 | 16.2 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
| 0.2 | 3.6 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.2 | 7.7 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.2 | 16.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
| 0.2 | 20.7 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 0.2 | 2.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.2 | 36.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.2 | 3.1 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.2 | 3.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.2 | 2.6 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
| 0.2 | 3.0 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
| 0.2 | 33.7 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.2 | 9.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.2 | 6.5 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.2 | 4.4 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.2 | 1.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.2 | 5.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.2 | 2.8 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.2 | 1.1 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.2 | 1.8 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
| 0.1 | 2.1 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.1 | 1.2 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.1 | 3.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.1 | 9.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.1 | 2.2 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
| 0.1 | 4.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.1 | 3.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.1 | 1.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.1 | 4.0 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
| 0.1 | 2.4 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.1 | 3.4 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.1 | 5.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.1 | 1.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.1 | 1.5 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
| 0.1 | 4.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.1 | 1.2 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.1 | 5.4 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.1 | 3.3 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.1 | 1.4 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.1 | 1.6 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.1 | 1.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.1 | 2.2 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.1 | 3.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.1 | 1.7 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.1 | 1.0 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.1 | 1.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.1 | 0.4 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
| 0.1 | 3.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.1 | 0.8 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.1 | 0.8 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.1 | 0.2 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
| 0.1 | 1.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.1 | 0.7 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.1 | 1.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.1 | 2.2 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
| 0.1 | 1.8 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.1 | 1.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.1 | 1.2 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.1 | 1.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.1 | 1.8 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 0.1 | 0.6 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 0.1 | 2.4 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.0 | 1.5 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.0 | 4.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.0 | 0.6 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.0 | 3.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.0 | 4.1 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
| 0.0 | 0.6 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.0 | 0.3 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
| 0.0 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.0 | 0.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.0 | 0.3 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.0 | 0.9 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.0 | 1.1 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.0 | 0.6 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
| 0.0 | 0.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.0 | 1.0 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.0 | 0.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.0 | 1.3 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.0 | 0.8 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.0 | 0.2 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
| 0.0 | 0.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.0 | 0.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.0 | 0.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |